"Never forget that your clone is a living being. Like pets and even humans, clones have biological necessities that must be addressed. New owners can at times forget, and clones--especially ones placed into new circumstances--are often reluctant to bring them up..."
In 1873, Satoshi Akiko stepped out of the fuedal holdovers of rural Japan and into the modern world of pharmacy. Kyoto was on the up and up, and the Satoshi family made a name for themselves by cutting ahead of the curve regarding industrial distribution for their wares, and riding into the 20th century on the wave of progressive company policy, cross-media investment, and private outsourcing of medical research. The pharma boom of the 21st century rocketed the Satoshi name into household presence, though their milieu was limited mostly to the staples of combating common illness, improving skin health, and adding shine to the pearly whites of the world's suburban sprawl.
Everything changed when the Big War came and went.
Household remedies went out of style when organ transplants, blood transfusions, and genetic rehabilitation were necessary in the wake of the unfortunate global conflict. The Satoshi name continued with its typical fares, but a division in the family company began development of post-trauma aid and large-scale bodily repair: Jinteki Bioscience. The Jinteki brand focused on medical miracles, even some which came at the cost of human rights skepticism and temporary tariffs, but the advancements made in biological manufacturing outpaced the public setbacks. Spinal modems, neural incursion countermeasures, self-replicating organs, and all manner of genetic modification became eminently possible through Jinteki's lab processes, but the company remained slow to expand and did not press against the larger commercial sector out of reservation and traditional mores.
This attitude changed twenty years ago when the long-distant grandson of the family founder, Satoshi Hiro, rose to the position of chairman over Jinteki Bioscience. Hiro grew up watching the careful reticence of both branches of the company readily allowing for competitors to overshadow their product lines, marketing, and sheer technical innovation. When he rose to influence as the new chairman, Satoshi Hiro excused the board of directors in an instant, and purged the old guard of stodgy investors who pushed for slow, manageable growth and decried pushing the envelope of biological engineering. In the wake of the purge, Hiro rolled out a plan for a tremendous thrust into transhumanism--widespread G-modding, organic restructuring, digital lifeforms, and his pièce de résistance, the direct assault on Haas-Bioroid's labor solution: fully extant accelerated human clones.
Since the ascension of Chairman Hiro, Jinteki has undergone a massive corporate restructuring. Hiro was a lab contractor who became the head of the corporation's American sector before rising to his current post shortly after he unlocked the Accelerated In Vitro Maturation process. He moved the company's traditional holdings headquarters from NeoTokyo to the Nihongai District in New Angeles, all the better to raise a stoic, but purposed middle finger to Haas-Bioroid. Jinteki's testing sets the industry standard, both for the whole clones and also for organ deliveries. Its products are fully guaranteed to operate at the pinnacle of function for the entirety of their planned lifespans so long as the owner follows the regular maintenance schedule. This level of reliability assures customers that they have ample time to replace a older Jinteki "product" with the newest iteration--whether it is a trusted clone or a vital organ.
The rapidity of this physical move and core values shift came at the surprise of many, but those voices have been silenced. There is only the future, and the future is Jinteki androids--the clones, that is--not Satoshi drugs peddled over the counter for your aging mother. Each clone takes humanity one step closer to perfection.
What does Jinteki want?
- To remain one step ahead of transhumanist desires, in public policy and private preference
- To ensure that no one trusts a bioroid, after all, flesh is what we know to be real
- To package immortality and sell it at a premium
What doesn't Jinteki want?
- To get caught in another human rights scandal
- To have their G-modding tech stolen and resold
- To miss an opportunity for celebrity trust
Jinteki NPCs:
Caprice Nisei, clone
- Deferent, quiet, and happy to oblige the needs of newcomers and traditionalists alike
- Grown to blend in with pleasant and rough company alike, able to disappear in plain sight
- Is an honest-to-goodness psychic, as are all of her "sisters"
Akitaro Watanabe, sysop slicer
- Snaring hackers in rig-blowing feedback loops since he was eleven years old
- Often redirects infiltration attempts into a runner's own back account for fun and profit
- Will work for time added to his lifespan, just don't ask how he does it
No comments:
Post a Comment